Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...

In a bold step toward global health justice, Ugandan biotech company DEI BioPharma has announced it will begin manufacturing ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

The FDA has approved a revolutionary, long-acting injectable that could change the way HIV is prevented. The treatment is ...

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

Health-care experts and advocates say Gilead's HIV prevention shot could be a "wonder drug," but there is concerns about accessiblity.

A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.

New player emerges in 23andMe bankruptcy An Indian drug company has big plans for the East Bay An Indian drug company has big ...

The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...